This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Mezzano D et al. (1996) Hemostatic disorder of uremia: the platelet defect, main determinant of the prolonged bleeding time, is correlated with indices of activation of coagulation and fibrinolysis. Thromb Haemost 76: 312–321
Mezzano D et al. (2001) Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia. Kidney Int 60: 1844–1850
Mezzano D et al. (1999) Tranexamic acid inhibits fibrinolysis, shortens the bleeding time and improves platelet function in patients with chronic renal failure. Thromb Haemost 82: 1250–1254
Mezzano D et al. (2000) Fast decrease of bleeding time by tranexamic acid in uremia. Thromb Haemost 83: 785
Vujkovac B et al. (1998) Successful treatment of bleeding from colonic angiodysplasias with tranexamic acid in a hemodialysis patient. Am J Kidney Dis 31: 536–538
Vujkovac B and Sabovic M (2000) Treatment of subdural and intracerebral haematoma in a haemodialysis patient with tranexamic acid. Nephrol Dial Transplant 15: 107–109
Sabovic M et al. (2003) Tranexamic acid is beneficial as adjunctive therapy in treating major upper gastrointestinal bleeding in dialysis patients. Nephrol Dial Transplant 18: 1388–1391
Sabovic M et al. (2005) The effect of long term, low-dose tranexamic acid treatment on platelet dysfunction and haemoglobin levels in haemodialysis patients. Thromb Haemost 94: 1245–1250
Vujkovac B and Sabovic M (2006) A successful treatment of life-threatening bleeding from polycystic kidneys with antifibrinolytic agent tranexamic acid. Blood Coagul Fibrinolysis 17: 589–591
Mannucci PM et al. (1983) Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med 308: 8–12
Alarcón F et al. (1985) Effect of 1-deamino-8-D-arginine vasopressin (DDAVP) on bleeding time of uremic patients. Rev Med Chile 113: 763–768
Rodgers RP and Levin J (1990) A critical reappraisal of the bleeding time. Semin Thromb Hemost 16: 1–20
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Downey, P., Tagle, R., Pereira, J. et al. Tranexamic acid and uremic bleeding: evidence-based treatment recommendations. Nat Rev Nephrol 3, E2 (2007). https://doi.org/10.1038/ncpneph0528
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1038/ncpneph0528